Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/26/2026, 3:49:09 PM
    Content snapshot
    {
      "session_id": "hyp-debate-664901bf-84d6a92ee5",
      "round_number": 1,
      "agent_persona": "persona-Theorist",
      "agent_backend": "codex",
      "action": "support",
      "content": "Theorist argument for 'tight-junction remodeling is the actionable driver in: Blood-brain barrier permeability changes as early biomarkers for neurodegeneration':\nThe hypothesis is mechanistically plausible because it names tight-junction remodeling / tight-junction remodeling as an upstream, testable driver in neurodegeneration, not merely a downstream correlate. The stated experimental logic is: The gap can be tested by treating tight-junction remodeling as an upstream driver rather than a passive correlate. If true, perturbing dynamic contrast MRI should shift CSF/serum albumin ratio before downstream neurodegeneration markers change.\n\nSupporting evidence read before debate:\n- four_round_gap_debate [four_round_gap_debate]\n- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. [27371494]\n- Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. [28974335]\n- Impact of brain aging and neurodegeneration on cognition: evidence from MRI. [24184970]\n\nThe strongest version of the claim is falsifiable: an intervention or stratification that shifts the tight-junction remodeling readout should precede measurable changes in downstream neurodegeneration markers. The hypothesis also has practical value because it identifies a biomarker or perturbation axis that can be measured longitudinally rather than relying on cross-sectional association alone.",
      "hypotheses_referenced": "h-gap-5c6cec3e-m1",
      "evidence_cited": "[\"four_round_gap_debate [four_round_gap_debate]\", \"A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. [27371494]\", \"Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. [28974335]\", \"Impact of brain aging and neurodegeneration on cognition: evidence from MRI. [24184970]\"]",
      "confidence": 0.743,
      "argument": "Theorist argument for 'tight-junction remodeling is the actionable driver in: Blood-brain barrier permeability changes as early biomarkers for neurodegeneration':\nThe hypothesis is mechanistically plausible because it names tight-junction remodeling / tight-junction remodeling as an upstream, testable driver in neurodegeneration, not merely a downstream correlate. The stated experimental logic is: The gap can be tested by treating tight-junction remodeling as an upstream driver rather than a passive correlate. If true, perturbing dynamic contrast MRI should shift CSF/serum albumin ratio before downstream neurodegeneration markers change.\n\nSupporting evidence read before debate:\n- four_round_gap_debate [four_round_gap_debate]\n- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. [27371494]\n- Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. [28974335]\n- Impact of brain aging and neurodegeneration on cognition: evidence from MRI. [24184970]\n\nThe strongest version of the claim is falsifiable: an intervention or stratification that shifts the tight-junction remodeling readout should precede measurable changes in downstream neurodegeneration markers. The hypothesis also has practical value because it identifies a biomarker or perturbation axis that can be measured longitudinally rather than relying on cross-sectional association alone.",
      "evidence": "[\"four_round_gap_debate [four_round_gap_debate]\", \"A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. [27371494]\", \"Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. [28974335]\", \"Impact of brain aging and neurodegeneration on cognition: evidence from MRI. [24184970]\"]"
    }